机译:佐剂化疗和术后放疗高危软组织肉瘤患者由生物危险因素定义 - 斯堪的纳维亚赛马群体研究(SSG XX)
Oslo Univ Hosp Norwegian Radium Hosp Dept Oncol Oslo Norway;
Oslo Univ Hosp Norwegian Radium Hosp Dept Oncol Oslo Norway;
Oslo Univ Hosp Norwegian Radium Hosp Dept Pathol Oslo Norway;
Oslo Univ Hosp Div Orthopaed Surg Oslo Norway;
Oslo Univ Hosp Norwegian Radium Hosp Dept Pathol Oslo Norway;
Reg Canc Ctr South Lund Sweden;
Sahlgrens Univ Hosp Dept Oncol Gothenburg Sweden;
Uppsala Univ Hosp Dept Oncol Uppsala Sweden;
Skane Univ Hosp Dept Oncol Lund Sweden;
St Olavs Univ Hosp Dept Oncol Trondheim Norway;
Norrlands Univ Hosp Dept Oncol Umea Sweden;
Linkoping Univ Hosp Dept Oncol Linkoping Sweden;
Haukeland Hosp Dept Musculoskeletal Tumour Serv Oncol Bergen Norway;
Karolinska Inst Dept Mol Med &
Surg Stockholm Sweden;
Skane Univ Hosp Dept Oncol Lund Sweden;
Soft tissue sarcoma; Adjuvant treatment; Prognostic factors; Vascular invasion; Growth pattern; Tumour size; Necrosis; Survival;
机译:佐剂化疗和术后放疗高危软组织肉瘤患者由生物危险因素定义 - 斯堪的纳维亚赛马群体研究(SSG XX)
机译:斯堪的纳维亚肉瘤小组研究(SSG XIII)的五年结果显示,辅助化疗联合加速放疗可治疗四肢和躯干壁高危软组织肉瘤
机译:II期研究评估高危软组织肉瘤的新/辅助EIA化疗,手术切除和放疗
机译:用软组织肉瘤患者肿瘤生物标志物优化元组化疗
机译:近红外光谱,评估软组织肉瘤患者骨骼肌氧合的运动诱导的变化:初步调查
机译:术前加速放疗与化疗相结合以患有高风险软组织萨马达患者的定义群体:斯堪的纳维亚赛马虫集团研究
机译:术前加速放疗与化疗相结合,以患有高风险软组织萨马达患者的定义群体:斯堪的纳维亚赛马虫集团研究